Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030133 · ClinicalTrials.gov registry record · NA
Effects of Transcranial Magnetic Stimulation (TMS) and Stimulus Controllability on Pain Perception
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01030133: Completed NA study, sponsored by Medical University of South Carolina.
NCT01030133 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030133, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Although transcranial magnetic stimulation (TMS) is now considered a minimal risk intervention, is approved for the treatment of depression, and is widely used around the world, little is known about mechanisms of action of prefrontal rTMS for depression or pain. There is some evidence that the prefrontal cortex is involved in perception of control and may moderate the effects of perceived controllability on emotional reactivity to painful stimuli. The present study aims to investigate the effects of prefrontal rTMS and perceived controllability on pain perception in healthy adults.
Primary Outcome
The perceived control condtion of the pain task consisted of 30 trials of 1 to 4 seconds of thermal stimulus accompanied by 5 seconds of real or sham TMS). The entire pain task (perceived control condition and no control condition) consisted of 60 trials. Participants in the operator role group rated the unpleasantness of each thermal stimulus on a computerized visual analog scale (VAS). Unpleasantness ratings are on a scale of 0 to 100. 0=not unpleasant. 100=extremely unpleasant. The ratings we
Interventions
- DEVICE Operator Role Real TMS
- DEVICE Receiver Role Real TMS
- DEVICE Operator Role Sham TMS
- DEVICE Receiver Role Sham TMS
- DEVICE All Participants Operator Role
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT01030133 record still lists
NCT01030133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Operator Role Real TMS is the first listed.
NCT01030133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01030133 about?
NCT01030133 is a clinical study titled "Effects of Transcranial Magnetic Stimulation (TMS) and Stimulus Controllability on Pain Perception". Although transcranial magnetic stimulation (TMS) is now considered a minimal risk intervention, is approved for the treatment of depression, and is widely used around the world, little is known about mechanisms of action of prefrontal rTMS for depression or pain. There is some evidence that the pref...
What is the current status of trial NCT01030133?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2009-10. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01030133?
The interventions under investigation include: Operator Role Real TMS (DEVICE), Receiver Role Real TMS (DEVICE), Operator Role Sham TMS (DEVICE), Receiver Role Sham TMS (DEVICE), All Participants Operator Role (DEVICE).
Who is sponsoring clinical trial NCT01030133?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01030133's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia